IMMIX BIOPHARMA, INC. Cash Flow Charts

2 quarters of history · ending 2022-12-31 · SEC EDGAR

Source:10-K · 10-Q

Capital Allocation

How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).

Capital Allocation Waterfall

Buybacks vs Stock-Based Comp

Cash Flow by Activity

Operating Cash Flow
Free Cash Flow
Investing Cash Flow
Financing Cash Flow
$424K
Capex
Stock Buybacks
$44K
Stock-Based Comp
$230K
Debt Repaid
D&A
$566
SBC Allocated Expense
$183K